Pharmacogenetics of schizophrenia in real clinical practice: a clinical case

Schizophrenia is a socially significant mental disorder characterized by early onset and high time and financial expenditure on treatment. The basic drugs in these patients are antipsychotics that are highly effective against the positive and negative symptoms of schizophrenia, but at the same time...

Descripció completa

Dades bibliogràfiques

Autors principals:	R. F. Nasyrova, N. A. Schnaider, K. O. Mironov, G. A. Shipulin, O. P. Dribnokhodova, E. A. Golosov, M. Yu. Tolmachev, B. V. Andreev, A. A. Kurylev, L. Sh. Akhmetova, О. V. Limankin, N. G. Neznanov
Format:	Artigo
Idioma:	Russo
Publicat:	IMA-PRESS LLC 2018-12-01
Col·lecció:	Неврология, нейропсихиатрия, психосоматика
Matèries:	pharmacogenomics pharmacogenetics antipsychotics schizophrenia p-glycoprotein cytochrome p450
Accés en línia:	https://nnp.ima-press.net/nnp/article/view/1002
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!